HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
This milestone reflects our shared commitment to Corporate Social Responsibility (CSR) throughout 2023.
It showcases the key initiatives and achievements that drive our company towards greater sustainability and responsibility.
This report is the result of a true team effort, and we extend our warmest thanks to everyone who contributed to making it.
🔗 Discover the 2023 CSR Report here
Beyond together, sustainably.
HTL Biotechnology is recognized for the second consecutive year among France’s most dynamic and innovative mid-sized companies.
On October 28, 2025, HTL Biotechnology hosted its first-ever webinar, “Shaping the Future of Aesthetic Medicine with Premium Biopolymers,” a key initiative to strengthen our presence in Asia and promote the “Feel the Difference with HTL Inside” positioning among major players in aesthetic medicine.
This October, HTL Biotechnology turned pink to support breast cancer prevention.